000			02129 a2200625 4500
005			20250518091039.0
264		0	_c20200630
008			202006s 0 0 eng d
022			_a1432-0851
024	7		_a10.1007/s00262-020-02534-7 _2doi
040			_aNLM _beng _cNLM
100	1		_aVoloshin, Tali
245	0	0	_aTumor-treating fields (TTFields) induce immunogenic cell death resulting in enhanced antitumor efficacy when combined with anti-PD-1 therapy. _h[electronic resource]
260			_bCancer immunology, immunotherapy : CII _cJul 2020
300			_a1191-1204 p. _bdigital
500			_aPublication Type: Journal Article
650	0	4	_aAnimals
650	0	4	_aAntineoplastic Agents, Immunological _xpharmacology
650	0	4	_aApoptosis
650	0	4	_aCarcinoma, Hepatocellular _ximmunology
650	0	4	_aCarcinoma, Lewis Lung _ximmunology
650	0	4	_aCell Proliferation
650	0	4	_aCombined Modality Therapy
650	0	4	_aElectric Stimulation Therapy _xmethods
650	0	4	_aFemale
650	0	4	_aHumans
650	0	4	_aImmunogenic Cell Death
650	0	4	_aLiver Neoplasms _ximmunology
650	0	4	_aLymphocytes, Tumor-Infiltrating _ximmunology
650	0	4	_aMale
650	0	4	_aMice
650	0	4	_aMice, Inbred BALB C
650	0	4	_aMice, Inbred C57BL
650	0	4	_aProgrammed Cell Death 1 Receptor _xantagonists & inhibitors
650	0	4	_aTumor Cells, Cultured
650	0	4	_aXenograft Model Antitumor Assays
700	1		_aKaynan, Noa
700	1		_aDavidi, Shiri
700	1		_aPorat, Yaara
700	1		_aShteingauz, Anna
700	1		_aSchneiderman, Rosa S
700	1		_aZeevi, Einav
700	1		_aMunster, Mijal
700	1		_aBlat, Roni
700	1		_aTempel Brami, Catherine
700	1		_aCahal, Shay
700	1		_aItzhaki, Aviran
700	1		_aGiladi, Moshe
700	1		_aKirson, Eilon D
700	1		_aWeinberg, Uri
700	1		_aKinzel, Adrian
700	1		_aPalti, Yoram
773	0		_tCancer immunology, immunotherapy : CII _gvol. 69 _gno. 7 _gp. 1191-1204
856	4	0	_uhttps://doi.org/10.1007/s00262-020-02534-7 _zAvailable from publisher's website
999			_c30715062 _d30715062